Tag: Cdiff

Ministry of Finance

Destiny Pharma PLC making significant strides towards phase III evaluation of potential breakthrough C.diff treatment

June 4, 2021
Lavern Vogel

CEO Neil Clark explained: “We have manufactured important progress considering the fact that closing the £10.4mln…